Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2021-A00544-37 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
People in Administrative Detention Centers often come from areas of medium or high HIV, hepatitis C & B endemic, and are often unaware of their serological status. Currently, HIV, hepatitis C & B screening is not systematically performed at the CRA of Nîmes, and when performed, serological tests are used. The main disadvantage of this method is the length of time it takes to obtain the results, with subjects frequently discharged before receiving their results.
To improve the care of these vulnerable persons, the aim of this study is to estimate the prevalence of HIV, hepatitis C and hepatitis B in the detainees of the administrative detention center of Nîmes, by systematically screening with a rapid diagnosis test. In case of a positive rapid diagnosis test test, a serology test will confirm the rapid diagnosis test result.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Detainees in an Administrative Detention Center | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rapid diagnosis test against HIV and hepatitis C and B | Diagnostic Test | combined Insti VIH® + Toyo VHC®, then First response Ag Hbs tested on capillary blood sample |
|
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of HIV infection in detainees at the Nîmes Administrative Detention Center | Rapid diagnosis test: Positive/negative | Inclusion |
| Prevalence of Hepatitis C infection in detainees at the Nîmes Administrative Detention Center | Rapid diagnosis test: Positive/negative | Inclusion |
| Prevalence of Hepatitis B infection in detainees at the Nîmes Administrative Detention Center | Rapid diagnosis test: Positive/negative | Inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of co-infections between HIV, Hepatitis C and Hepatitis B | Yes or no for co-infection (HIV-Hep C / HIV-Hep B / HepC-HepB / Hiv-HepC-HepB) | Inclusion |
| Participant country of origin | Country name |
Not provided
Inclusion Criteria:
Exclusion Criterion
• It is impossible to give the subject informed information
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mélanie Kinne | Centre Hospitalier Universitaire de Nīmes | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Nîmes | Nîmes | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38739355 | Result | Mancy S, Fabbro-Peray P, Alonso S, Berkaoui H, Lambremon L, Vidal H, Hilaire C, Herrmann D, Dapoigny J, Kinne M. Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in a French Administrative Detention Centre. J Epidemiol Glob Health. 2024 Sep;14(3):923-932. doi: 10.1007/s44197-024-00238-0. Epub 2024 May 13. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Inclusion |
| Knowledge of HIV, Hep C and Hep B status | Yes/no | Inclusion |
| Participant previous transfusion | Yes/no | Inclusion |
| Intravenous drug use | Yes/no | Inclusion |
| Intranasal drug use | Yes/no | Inclusion |
| Shared drug paraphernalia | Yes/no | Inclusion |
| Non-protected sexual activity | Yes/no | Inclusion |
| Participant with piercings | If yes, professional done or not | Inclusion |
| Participant with tattoos | If yes, professional done or not | Inclusion |
| Feasibility of screening | % of subjects with available samples (ie no subject refusal, subjects arriving at weekend or holiday, study not offered on a weekday, technical problem with test interpretation) | End of study (1 year) |
| Acceptability of the screening | % of subjects giving samples | End of study (1 year) |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D006526 | Hepatitis C |
| D006509 | Hepatitis B |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D006525 | Hepatitis, Viral, Human |
| D018178 | Flaviviridae Infections |
| D006505 | Hepatitis |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D018347 | Hepadnaviridae Infections |
| D004266 | DNA Virus Infections |
Not provided
Not provided